COX-2 is widely upregulated in many human cancers, including colorectal, prostate, breast, gastric, hepatic, lung, and head and neck cancers, as it is promoted by a variety of cytokines, growth factors, and tumor promoters [36]. This evidence concerns the gene PTGS2 and cancer.